Renovus Capital Partners' portfolio company BlueRidge Life Sciences has acquired Philadelphia-based Design Science, a human factors and usability engineering consultancy. The deal bolsters BlueRidge's life sciences consulting platform, which is based in Katy, Texas. Design Science serves medical device, pharmaceutical, and biotechnology clients globally and was founded in 1991.

This acquisition expands BlueRidge's service offerings in a critical niche. Human factors engineering is essential for medical device regulatory submissions, helping companies meet FDA requirements. By integrating Design Science's expertise, BlueRidge can offer a more comprehensive suite of services to its life sciences clients, potentially driving cross-selling opportunities and strengthening its competitive position.

Katie Hansbro, CEO of Design Science, will continue leading the business alongside its current team, ensuring continuity for clients. The move reflects a broader private equity trend of consolidating specialized consultancies to create scaled platforms. Investors will watch for further bolt-on acquisitions as Renovus builds out its BlueRidge portfolio in the growing life sciences services market.